Dmytro Shymkiv

News

Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion

18.04.2021 News

Traditionally, it is considered that the shares of pharmaceutical and biotech corporations are effectively protected from the global financial crises. The asset growth inevitably accompanies any, even insignificant, success of drug manufacturers. And the pandemic period has caused an unprecedented wave of investments in the pharmaceutical business. Due to Dmytro Shymkiv’s explanation, the head of the Boards of Directors of Darnytsia Group, investors are enticed by rather the pharmaceutical industry’s innovativeness than pharmaceutical factories’ products.

To support his statement, Shymkiv gives an example of the leaders in the pharmaceutical market. Moderna, whose Covid-19 vaccine is 94.5% effective, sold its shares three times when its price was increasing. Novovax shares rose 20% within an hour after the news that their vaccine was 96% effective. The innovativeness of these companies allowed them to develop a protecting drug against coronavirus in an unprecedentedly short time frame. At the same time, Dmytro Shymkiv clarifies that the consistent implementation of new technologies is the prerogative not only of such global leaders in the pharmaceutical business as Moderna, Pfizer, Johnson & Johnson.

The innovative process in Darnytsia is rooted in the company’s DNA code and runs non-stop, moving simultaneously in all directions: from development and production to the staff. According to the head of the Board of Directors of Darnytsia, such a business approach has allowed this drug manufacturer to annually sell the largest volume of products among all existing Ukrainian pharmaceutical companies. Due to this, Ukrainians practically did not feel a lack of medicine last spring during the hype caused by the outbreak of Covid-19. Though, most other countries experienced a severe shortage of medicine for not having their own drug production.

Dmytro Shymkiv notes that constant work on improving technologies allowed the Darnytsia factory to be one of the first in Ukraine to gain a GMP (Good Manufacturing Practice) quality certificate, which enabled Darnytsia Group to enter the European and global pharmaceutical market.

According to Shymkiv, the coronavirus crisis has radically changed the direction of pharmaceutical corporations’ development. It made them ponder on preventive medicine. Darnytsia keeps up with global trends and is actively working on building a strategy for implementing such projects by proceeding in innovations and investing in Ukrainians’ health.

Other articles

Read also

Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Another Ukrspirt plant was sold at auction for 90 million

The State Property Fund held an auction for the privatization of the property of the Ivankivka distillery located in the Cherkasy region. According to its results, the state budget should receive 90 million hryvnias, according to the agency’s website. It is noted that six participants competed for ownership at the open auction, which increased the […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Buffett’s company increased a quarterly net profit to 87%

The investment company of billionaire Warren Buffett’s Berkshire Hathaway in the II quarter 2020 net income increased due to higher cost of investment after the rise of stock markets and the collapse in the first quarter due to coronavirus pandemic. During the reporting period the company received $ 26.3 billion in net profit to $ […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

The Russians sold the Radisson Hotel: buyer’s name was not disclosed

Representatives of the Russian corporation Hotel Development reported the signing of an agreement for the sale of the hotel Radisson Blu Hotel Kiev Podol, previously owned by foreign shareholders. Estimated value of the transaction is approximately $ 10 million. With regard to information about the new owner of the four-star hotel in the prestigious district […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

The Ministry of Finance named the main risks of the economy in 2022

Next year, Ukraine may face a number of macroeconomic risks that will greatly affect economic growth. The Ministry of Finance listed these risks. In particular, Ukraine may lose 0.6-0.8 percentage points of GDP growth due to too low grain yields, due to which the budget will not receive UAH 8.5 billion. At the same time, […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

“Pan Kurchak” enters the European market

The “Pan Kurchak” agroindustrial group  got permission to export chicken to the EU. This is the third Ukrainian company, besides the MHP and “Agromars” Complex” that can ship products to Europe. Products designed for the European market will be produced at the facilities of “Gubin” poultry complex”, which were upgraded in 2015. “The advantage with […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

PIFs brought a million dollars to the budget for the year

Currently, there are almost 2 million entrepreneurs in Ukraine, and each of them pays an average of 13 thousand hryvnias a year. Thereby, in 2019, the turnover of the PIF`s economy amounted to 1 million dollars. “Over the past eight years, revenue from private individuals to the budget have increased by 24 times. In the […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Nataliya Osadchaya: “Engaged in prevention of raiding at a stage of entry into the project, because treatment can not salvage”

The subject of raiding remains urgent and at the same time very painful for Ukraine, especially for foreign investors. It isn’t accepted to speak about it openly. The  victims of similar captures in rare instances make public the fact of their entities occupation. Syutkin & Partners Law Firm together with USUBC, the Ministry of Justice […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Mondelis Ukraine will export its products to The EU and the Arab world

Mondelis Ukraine company (Kraft Foods Inc.) has invested $ 9 million in the purchase of new technical equipment for Trostiyanetska chocolate factory and started export of its products in 12 EU countries. The company also plans to increase the quantitative measure of the supply on the European market and in the countries of the Arabian […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Yuzhmash provides Antares Carrier Rocket Shipment to the USA

According to Interfax-Ukraine, the State Enterprise  Production Association Yuzhny Machine-Building Plant named after A.M. Makarov (Yuzhmash) has provided the  first step of Antares carrier rocket (CR) medium-class shipping  by the interests of Orbital ATK Inc. (NYSE: OA) Company. The international space station renewed the cargo flight after CR modernization with Mild-Atlantic Regional Spaceport due to […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Analysts have named the next global reserve of the currency

Chinese yuan in the next ten years could become the third global reserve currency after the dollar and euro. Such conclusion was reached by analysts of Morgan Stanley, writes CNBC. The growth of investment in the Chinese economy is called to be the reason for the increase in demand for the yuan. Currently, it accounts […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
Analytics

What help Ukrainian entrepreneurs need to export more

Exports of goods accounts for a third of Ukraine’s GDP.But we sell primarily raw materials abroad. It is a marker of underdeveloped countries and a path that does not contribute to economic development. Our state’s strategic task is to increase the exports of high-tech goods with high added value: that is, not just to grow […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Fairfax holding company acquired a part of Astarta shares

International financial company Fairfax Financial Holdings Limited (Toronto headquarters, Canada) purchased 9.99% of shares of agricultural Ukrainian holding Astarta, which is the flagship of the domestic sugar market, which also is one of the largest provider of milk in the country. In addition,a new owner of shares acquired the right to purchase the remaining interest […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Amazon has banned the import of seeds into the United States

Amazon has banned the import of seeds to the United States because the Americans received thousands of parcels from unknown shippers from China. In this regard, Amazon informed foreign partners of its decision and obliged sellers to remove publications with appropriate proposals. Now sell the seeds only can those who is in the United States, […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

The regulator has approved new tariffs for mobile operators

The National Commission for the State Regulation of Communication and Informatization has reduced the inter-operator tariff. The NCCIR press service reports. From July 1, 2021, market participants will pay 7 kopecks per minute of outgoing call for a local call and 10 kopecks for long distance. Moreover, from January 1, 2022, rates will reduce to […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

JPMorgan could pay a record of $ 1 billion for the manipulating traders in the markets

Right away three the U.S. agencies announced on Tuesday, Sept. 29, to reach the agreement with JPMorgan Chase for the end of the criminal prosecution of the bank in exchange for the payment of multimillion fines. In total, the company must pay the US government more than $ 920 million. Statement from the Freight Exchange […]

Next
Why it is worth investing in pharmaceuticals, — Dmytro Shymkiv’s opinion
News

Ukraine will recover from the coronary crisis in two or three years

The Ukrainian economy will recover from the effects of the corona crisis in two or three years. This assessment of experts was published by the Ministry of Economy in a report on the impact of coronavirus on Ukraine. The agency reminded that last year the economy lost 4%, but this year GDP is expected to […]

Next
WP2Social Auto Publish Powered By : XYZScripts.com